Phosphatase and tensin homolog deleted on chromosome 10 (Pten) is a tumor suppressor protein whose loss of lipid phosphatase activity is associated with lymphomagenesis. We made use of the Cre-loxP system to delete Pten expression in Lck-or CD4-expressing T-lineage cells. Mice initially showed modest thymic hyperplasia and subsequently developed expanding and infiltrating T-cell lymphomas, leading to a premature death within 5 to 23 weeks. Frequently, all thymocyte and peripheral T-cell populations displayed phenotypes characteristic for immature developing thymocyte precursors and shared elevated levels of clonally rearranged T-cell receptor (TCR) b chains. In concert, CD2, CD5, CD3e and CD44, proteins associated with increased expression and signaling capacity of both the immature pre-TCR and the mature abTCR, were more abundantly expressed, reflecting a constitutive state of activation. Although most T-cell lymphomas had acquired the capability to infiltrate the periphery, not all populations left the thymus and expanded clonally exclusively in the thymus. In line with this, only transplantation of thymocytes with infiltrating capacity gave rise to T-cell lymphoma in immunodeficient recipients. These results indicate that T-cell-specific Pten deletion during various stages of thymocyte development gives rise to clonally expanding T-cell lymphomas that frequently infiltrate the periphery, but originate in the thymus.
Introduction
Phosphatidylinositol-3 kinases (PI3Ks) are members of a large family of lipid kinases that regulate survival, proliferation, motility, activation, adhesion and possibly differentiation of lymphoid cells. [1] [2] [3] [4] The class IA PI3Ks are recruited to activated antigen receptors, costimulatory molecules and cytokine receptors and are activated through phosphorylation events. 2, 3, 5 Activated PI3K phosphorylates the D-3 position of the inositol ring of the plasma membrane lipid phosphatidylinositol-(4,5)-biphosphate (PIP 2 ) to give rise to elevated amounts of phosphatidylinositol-(3,4,5)-triphosphate (PIP 3 ) second messenger molecules. PIP 3 subsequently recruits the pleckstrin homology (PH) domain-containing intracellular enzyme phosphoinositide-dependent kinase 1 (PDK1) to the cell membrane, which in its turn phosphorylates the co-recruited PH domain-containing Akt/protein kinase B (PKB) at Thr308. 6 Full activation of Akt/PKB is mediated by the Rictor-mammalian target of rapamycin (mTOR) complex, which phosphorylates Akt/PKB at Ser473. 7 Akt/PKB subsequently phosphorylates a number of downstream targets such as tuberous sclerosis complex 2 (TSC2), glycogen synthase kinase 3b (GSK3b) and IkB-kinases. [8] [9] [10] It is well established that PI3K plays an important role in multiple stages of T-cell development in the thymus. Early murine thymocyte development is critically dependent on cKitand interleukin-7 receptor (IL-7R)-mediated signal transduction pathways, and regulate PI3K-mediated proliferation of the most immature T-cell lineage progenitors, namely, the CD4 À CD8 14 Successful rearrangement of the T-cell receptor (TCR) b chain gene locus and subsequent expression of a functional pre-TCR at the cell surface are essential for developing ab T-cell lineage DN3a thymocytes to be selected in a process called b-selection. [14] [15] [16] [17] In this process, DN3a thymocytes expressing a functional pre-TCR are rescued from apoptosis, and subsequently, pre-TCR signaling induces massive proliferation. As the mature abTCR has been shown to induce activation of the PI3K pathway, 5 and the structure of the pre-TCR and the abTCR are similar, 18 it is likely that the pre-TCR can induce PI3K-dependent survival and proliferation. Indeed, pre-TCR signaling has recently been indicated to phosphorylate Akt/PKB. 19 Next to pre-TCR signaling, DLL1/Notch signaling has been indicated to be important, as DN3a TCRb þ cells fail to pass b-selection in the absence of extracellular DLL1 in vitro.
14 b-Selected CD44
DN3b cells upregulate CD27, CD2 and CD5, which are thought to be proportional to both the cell surface level and the signaling capacity of the pre-TCR. 15, 20, 21 Following downregulation of CD25 to become CD44 À CD25 À DN4 cells, cells quickly differentiate via an immature single-positive CD8
þ double-positive (DP) cells. After successful rearrangement of the TCRa chain and high cell surface expression of the mature abTCR, DP cells are subjected to positive and negative selection, CD4 or CD8 expression is downregulated and single-positive (SP) CD4 þ and SP CD8 þ cells leave the thymus to populate the periphery. Direct negative regulation of PI3K activity is provided by the phosphatase and tensin homolog deleted on chromosome 10 (Pten). Pten dephosphorylates PIP 3 into PIP 2 . 22 Dysregulation of the lipid phosphatase activity of Pten or loss of Pten expression results in uncontrolled activation of the PI3K pathway, and leads to tumor formation in many types of tissues. 4, [23] [24] [25] PI3K is regulated by cKit, IL-7R, (pre-)TCR, CD28 and possibly Notch receptors during thymocyte development, 2, 3, [11] [12] [13] [14] and inactivating Pten mutations, Pten deletions and constitutive activation of Akt/PKB are frequently observed in T-cell lymphomas.
We showed previously that in mice Lck-Cre-mediated deletion of exon 5 of the Pten gene led to a complete loss of Pten expression in thymocytes, resulting in constitutive phosphorylation of Akt/PKB and increased survival in vitro. 28 Here, we performed an extensive analysis of these mice as well as of mice in which Pten was abolished by Cre expressed under control of the CD4 promotor. 29 At young age (o5 weeks), these mice appeared healthy, although a slight thymic hyperplasia was noted. However, clinical signs of T-cell lymphomagenesis were observed over time and mice suffered a premature death. Upon analysis, massively expanded immature thymic populations were found in the thymus and the periphery, most of which shared elevated cell surface expression levels of CD2, CD5, CD44, CD3e and TCRb chains that displayed strongly restricted heterogeneity of the variable region (TCRvb) segments. These data indicate that Pten loss allowed a single or a limited number of thymic progenitors to enhance (pre-)TCR signaling to expand to give rise to infiltrating lymphoma. However, some thymic populations expanded exclusively in the thymus, and only transplantation of malignant Pten-deficient thymocytes with infiltrating capacity gave rise to clonally expanding and infiltrating T-cell lymphoma in immunodeficient recipients. Taken together with the fact that Cre-mediated deletion of Pten in these mice is initiated when developing thymocytes start to express Lck or CD4, these results indicate that T-cell lymphomagenesis observed in T-cell-specific Pten-deficient mice originates in the thymus.
Materials and methods

Generation, genotyping and monitoring of mice
The conditional vector, the generation of mice carrying the Pten flox allele by blastocyst microinjection and PCR detection of the Pten flox allele have been described previously. 28, 30 To generate T-cell-specific Pten-deficient mice, Pten flox/flox mice were crossed with proximal Lck promotor (Lck)-Cre mice 31 or with CD4 promotor (CD4)-Cre mice 29 (kindly provided by Dr C Wilson, University of Washington, Seattle, WA, USA and Dr RW Hendriks, Erasmus University, Rotterdam, the Netherlands). PCR detection of the Lck-Cre and CD4-Cre transgenes was described previously. 28, 29 Mice were maintained under specific pathogen-free conditions in the animal colonies of the Netherlands Cancer Institute (Amsterdam, the Netherlands), the Academic Medical Center (Amsterdam, the Netherlands) and Genentech Inc. (South San Francisco, CA, USA). Mice were killed at different time points after birth to monitor T-cell development in a Pten-deficient background, 28 and to monitor the onset of T-cell lymphomagenesis. Clinical signs of T-cell lymphomagenesis included lethargy, ruffling of fur, hunched posture, shallow breathing and social isolation.
Isolation of cells
Harvested organs were homogenized using 1 ml syringe plungers and 40-70 mM cell strainers (BD Biosciences, Bedford, MA, USA). Cells were resuspended in Iscove's Modified Dulbecco's Medium (Life Technologies, Paisley, Scotland) supplemented with 8% fetal calf serum (FCS) (ICN, Strasbourg, France). Cells were stained with 0.4% Trypan blue solution (Mediatech, Herndon, VA, USA) and viable cells were counted.
Histologic staining and microscopic image capture
Sections of thymus, spleen, lymph nodes, liver, kidney and sternal bone were fixed in 10% neutral buffered formalin, paraffin embedded and sectioned at 5 mm. For routine histologic analysis, sections were stained with hematoxylin and eosin. For detection of CD3e and B220, sections were first incubated for 20 min at 99 1C in Target Retrieval Solution (Dako, Carpinteria, CA, USA). Next, endogenous peroxidase was quenched using a blocking buffer (KPL, Gaithersburg, MD, USA) and avidin and biotin were quenched with an avidin/biotin kit (Vector, Burlingame, CA, USA). Sections were then incubated in either 10% normal goat serum (for CD3e) or 10% normal rabbit serum (for B220) in 3% BSA/PBS, followed by 60 min at room temperature with 7.5 mg ml À1 of a rabbit anti-human CD3e immunoglobulin G (IgG) monoclonal antibody that cross-reacts with mouse CD3e (clone SP7; Lab Vision, Fremont, CA, USA), or with 2.5 mg ml À1 of a rat anti-mouse B220 IgG2a mAb (clone RA3-6B2; BD Pharmingen, San Diego, CA, USA). After Trisbuffered saline washes, sections were incubated for 30 min with 2.5 mg ml À1 biotinylated goat anti-rabbit IgG secondary antibody (Vector) or with 2.5 mg ml À1 biotinylated rabbit anti-rat IgG secondary antibody (Vector), followed by Vectastain ABC Elite (Vector) for 30 min. The staining reaction was detected using metal enhanced 3,3 0 -diaminobenzidine chromogen (Pierce Chemical, Rockford, IL, USA) for 4 min. Slides were counterstained with Mayer's hematoxylin to stain nuclei. Microscopic images were captured using a Nikon DXM1200C digital camera on a Nikon Eclipse E800 microscope (Nikon Instruments, Melville, NY, USA).
Flow cytometric analysis
All monoclonal anti-mouse antibodies to CD2, CD3e, CD4, CD5, CD8a, CD44, pan-TCRb, TCRvb2, TCRvb3, TCRvb4, TCRvb5. Upon manifestation of clinical signs of T-cell lymphomagenesis, mice were killed. Thymus, spleen, liver, kidney and blood were harvested, homogenized and analyzed by Trypan blue exclusion cell counts and flow cytometry as indicated.
Statistical analysis
Time to fatal illness among Pten flox/flox Â Lck-Cre and Pten flox/flox Â CD4-Cre mice was analyzed using the Kaplan-Meier method. Factors associated with missing cell counts were identified using logistic regression. Cell counts from healthy and tumor-bearing Pten flox/flox Â Lck-Cre mice and Pten flox/flox Â CD4-Cre mice were compared to cell counts from wild-type control mice using age-adjusted log-linear regression with Poisson distribution and are depicted in absolute cell numbers. Recognizing that subjects belonged to genetically identical clusters (Pten flox/flox Â Lck-Cre, Pten flox/flox Â CD4-Cre or wild-type genotype), regression models of cell counts employed generalized estimating equation solutions, with cluster included as a random variable and specifying an exchangeable working correlation structure to avoid underestimation of standard errors.
Results
T-cell-specific Pten deficiency induces premature death
To investigate the role of Pten in T-cell lymphomagenesis, Pten flox/flox Â Lck-Cre mice (n ¼ 125), Pten flox/flox Â CD4-Cre mice (n ¼ 5) and wild-type control mice (n ¼ 144) were followed from birth. All wild-type control mice remained healthy during the course of the study (data not shown). The first clinical signs of T-cell lymphomagenesis in Pten flox/flox Â Lck-Cre mice were observed 30-42 days after birth (Figure 1 and data not shown), Figure 1 and data not shown). As Lck-Cre-mediated loxP-site-specific recombination has been shown not to occur with maximum efficiency, 31 the exceptional longevity of these mice may reflect rare occasions in which Cre-mediated perturbation of Pten expression was absent in the majority of T-lineage cells. Pten flox/flox Â CD4-Cre mice showed T-cell lymphomagenesis kinetics similar to Pten flox/flox Â Lck-Cre mice: before 35 days of age, no clinical signs of T-cell lymphomagenesis were observed. From 49 days after birth, the first clinical signs of T-cell lymphomagenesis became apparent, and all mice died within 79 days (data not shown).
Increased thymic cellularity does not correlate with spleen cellularity in healthy T-cell-specific Pten-deficient mice Thymocyte cell counts of Pten flox/flox Â Lck-Cre mice were significantly higher than wild type: at time of fatal illness markedly elevated mean (log) thymus cell counts were observed (by 1.354 ( ± 0.018) logs, Po0.001) (Figure 2b ). Importantly, a modest but significant increase in thymus cellularity was also observed when healthy Pten flox/flox Â Lck-Cre mice were compared to wild-type control mice (by 0.147 ( ± 0.002) logs, Po0.001) (Figure 2b ), likely reflecting increased resistance of thymocytes to apoptosis and enhanced proliferation as a result of Pten loss. 4, 24, 28 Furthermore, this suggests that although healthy Pten flox/flox Â Lck-Cre mice, in particular subjects older than 58 days, did not show apparent clinical signs of T-cell lymphomagenesis, Pten was at least partially deleted in a population of thymocytes in these mice, resulting in a modest thymic hyperplasia.
Splenocyte to 1488 Â 10 6 thymocytes and 370 Â 10 6 to 1240 Â 10 6 splenocytes), significance was not reached.
Pten-deficient CD3e
þ thymocytes expand and infiltrate the periphery Hematoxylin and eosin staining of thymic sections derived from tumor-bearing Pten flox/flox Â Lck-Cre mice revealed a complete loss of cortico-medullary structure (Figures 3a and b) . In addition, immunohistochemical analysis using monoclonal T-cell-specific Pten-deficient mice TJ Hagenbeek and H Spits antibodies against CD3e and B220 revealed the excessive presence of large neoplastic CD3e þ lymphocytes with relatively abundant basophilic cytoplasm, large nuclei with marginated chromatic and prominent nucleoli in the thymus (Figure 3c ). CD3e þ cells were also observed in large quantities in Pten flox/flox Â Lck-Cre spleen (Figures 3d-f) , kidney (Figures 3g and h ), liver (Figures 3i and j) , lymph nodes (data not shown), bone marrow (data not shown) and connective tissue surrounding the bone (data not shown). Excessive expansion and infiltration of B220 þ B-lineage lymphocytes was never observed (data not shown). Flow cytometric analysis of homogenized organs confirmed that T-lineage cells never coexpressed B220 (data not shown). These results indicated that malignant Pten-deficient thymocytes that expressed a (pre-)TCR had infiltrated the periphery. þ population in combination with a DP T 
Pten-deficient thymocytes and peripheral T cells display CD4 CD8 expression patterns characteristic for thymic populations
-cell-specific Pten-deficient mice TJ Hagenbeek and H Spits (1 of 12) or a DN (1 of 12) population in the periphery
Clonal expansion and peripheral infiltration of activated Pten-deficient thymocytes
Malignant and clonal T-cell development has been shown to be characterized by a massive expansion of activated T cells that display a strongly restricted heterogeneity of the TCRb variable region (TCRvb) segment. 24, [34] [35] [36] [37] [38] Indeed, flow cytometric analysis revealed that the majority of thymocytes and 
T-cell-specific Pten-deficient mice (Figure 4d and data not shown) and pan-TCRb (data not shown) at elevated cell surface intensity as compared to wild-type control cells, reflective of amplification of (pre-)TCR/PI3K signaling due to Pten loss to give rise to a constitutively activated state. To investigate whether a single or a limited number of thymocytes gave rise to all differentially expressing CD4 and CD8 thymic and peripheral populations as lymphomagenesis progressed, the heterogeneity of the TCRb variable region (TCRvb) segment of DN, DP, ISP/SP CD8 þ and SP CD4 þ thymic populations and related peripheral populations of 15 of 43 tumor-bearing Pten flox/flox Â Lck-Cre mice and 2 of 4 tumor-bearing Pten flox/flox Â CD4-Cre mice was determined by flow cytometry using a panel of 15 monoclonal TCRvb segment-specific antibodies. Results are summarized in Table 1 .
In 2 of 15 of tumor-bearing Pten flox/flox Â Lck-Cre cases, multiple TCRvb segments were detected, indicating that thymocytes had expanded polyclonally, or that transformation of a limited number of thymocyte progenitors had taken place at a developmental stage prior to TCRvb segment rearrangements to give rise to the polyclonal malignant thymic and splenic populations. In 3 of 15 tumor-bearing Pten flox/flox Â Lck-Cre mice, no specific TCRvb segments were detected although all 
T-cell-specific Pten-deficient mice (Figure 5c ), indicating that post-b-selected thymocytes that expressed TCRvb8.1/8.2 were initially transformed. However, most of the DP thymocytes exclusively expressed cell surface TCRvb8.3, while only a small peripheral TCRvb8.3 þ DP population was detected (Figure 5c , DP panels). This observation indicated that separate transformation events in TCRvb8.3 þ DP thymocytes gave rise to a clonally expanding noninfiltrating hyperplastic population. The large TCRvb8.1/8.2
þ DP peripheral population must have been derived either from clonally expanding TCRvb8.1/8.2 þ SP CD4 þ thymocytes or from the small TCRvb8.1/8.2
þ DP thymic population that expanded in the periphery.
Noninfiltrating hyperplastic Pten-deficient thymocytes fail to give rise to T-cell lymphoma after transplantation
In a 70-day-old tumor-bearing Pten flox/flox Â Lck-Cre mouse, transformation events in post-b-selected TCRvb7 þ and TCRvb17 a þ thymocytes gave rise to simultaneously expanding TCRvb7 þ and TCRvb17 a þ DN, DP, SP CD4 þ and SP CD8 þ thymocytes and subsequently to DN and SP CD4 þ peripheral cells with identical clonotype (Figure 6a) . Reminiscent of the mouse described in Figure 5c , separate transformation events after b-selection led to the clonal expansion of TCRvb14 þ DP thymocytes that were not capable to infiltrate the periphery; no TCRvb14 þ DP cells were detected in the spleen (Figure 6b ). Transplantation of whole thymocyte suspensions into gc À/À Â Rag2 À/À recipients confirmed that of all thymocytes, only the TCRvb7 þ and TCRvb17 a þ thymocytes, but not the hyperplastic TCRvb14 þ DP thymocytes, were able to infiltrate the periphery (Figures 6c and d, and data not shown) . Although hyperplastic TCRvb14 þ DP thymocytes contributed to thymic size increase and therefore probably to the premature death of the primary host, these observations indicated that only TCRvb7 þ and TCRvb17 a þ thymocytes were responsible for T-cell lymphoma manifestation and a premature death in the recipients, which occurred as soon as 19 days after transfer. It needs to be noted that small populations of TCRvb14 þ DN and SP CD4 þ cells were detected in the periphery of recipient mice ( Figure 6d) ; these cells probably represented transplanted DP thymocytes that lost expression of CD8, or both CD4 and CD8, which were allowed to survive due to Pten loss.
Discussion
In this study, we made use of the Cre-loxP recombination system to specifically and effectively knockout Pten expression in T-cell progenitors during two stages of thymocyte development. In Pten flox/flox Â Lck-Cre mice, Pten expression was abolished when developing DN thymocytes started to express Lck, 31 whereas in Pten flox/flox Â CD4-Cre mice, Pten was lost as thymocytes upregulated CD4 expression during differentiation toward the DP stage. 29, 39 Previously 28 and in this study, we have shown that both Pten flox/flox Â Lck-Cre mice and Pten flox/flox Â CD4-Cre mice were born alive and appeared healthy up until 5 weeks of age. However, although healthy T-cell-specific Pten-deficient mice were phenotypically nearly undistinguishable from wildtype littermates, Pten loss allowed a small nonexpanding TCRb À DP population to bypass death by neglect and to persist in the thymus. In line with this, Pten loss induced increased resistance to apoptosis by thymocytes in vitro, and possibly in concert with increased proliferation gave rise to a modest but significant thymic hyperplasia in vivo. This is reminiscent of reports showing increased apoptosis resistance and enhanced proliferation by thymocytes as a result of Pten loss, 4, 24, 40 leading to a modest thymic hyperplasia. 4 Consistent with this, forced expression of a constitutive active Akt/PKB (myrAkt/PKB) 19, 40 or PI3K (CA-PI3K) 41 increased survival and inhibited apoptosis in vivo. Conversely, deletion of Akt/PKB 19 or PI3K 42, 43 in vivo, or specific blockage of PI3K activity by forced expression of dominant-negative PI3K 2 or by using a small molecular inhibitor 19 in vitro, increased apoptosis, underlining the importance of the PI3K pathway to ensure survival of thymocytes.
No significant increase in spleen cellularity was observed in healthy Pten flox/flox Â Lck-Cre mice and Pten flox/flox Â CD4-Cre mice, contradicting several studies in which Pten loss in young mice gave rise to increased splenic cellularity, 4, [24] [25] [26] partially shown to be due to expansion of SP CD4 þ cells. 4 However, in these studies, Pten expression was downregulated or completely abolished in all cells, leading to increased mobilization and expansion of hematopoietic stem cells, B-lineage cells and myeloid-lineage cells to give rise to splenic hyperplasia, and possibly contributing to increased SP CD4 þ splenic cell counts, as both splenic T-and B cells with decreased Pten expression showed elevated activation.
4,24-26 T-cell-specific expression of CA-PI3K in healthy mice allowed splenic SP CD4 þ cells to expand exclusively toward hyperplasia, 41 indicative of a possible PI3K pathway-mediated enhanced expansion of this population in the periphery. The explanation of the variable expansion rate of peripheral SP CD4 þ T cells observed in different models that constitutively activate the PI3K pathway to study lymphoproliferative disorders remains elusive, but is possibly attributable to differences in genetic background or reflects an abnormal response to unidentified pathogens present in the different colonies.
T-cell-specific Pten-deficient mice inevitably developed fullblown T-cell lymphomagenesis over time, ultimately resulting in premature death. First deaths were observed 5-6 weeks after birth, 50% of mice had to be euthanized after 13 weeks and most mice suffered a premature death after 22 weeks. Although some mice only developed thymic T-cell lymphomas, most tumor-bearing mice had massively and often clonally expanded immature thymic populations that infiltrated the periphery, indicating that the observed T-cell lymphomas were derived from single or a limited number of thymic progenitors. DP thymic and peripheral populations were observed in most mice, either exclusively, or in combination with DN, ISP CD8 þ , SP CD8 þ and/or SP CD4 þ cells, the latter population being predominantly represented. In some cases, exclusive ISP CD8 þ , SP CD4 þ or DN/SP CD4 þ thymic and peripheral populations T-cell-specific Pten-deficient mice TJ Hagenbeek and H Spits were observed. The observation that SP CD4 þ T-cell lymphomagenesis dominated over SP CD8 þ T-cell lymphomagenesis is consistent with reports showing that enhanced Lck and PI3K signaling pathways promote CD4 þ T-cell differentiation. 44, 45 In this context, Pten loss may have amplified these pathways in developing thymocytes to transform them predominantly toward a SP CD4 þ T-cell fate. These results are in partial agreement with results obtained during studies using T-cell lymphoma-bearing mice that constitutively activate the PI3K pathway in thymocytes and peripheral T cells. Tumor-bearing Pten flox/À Â Lck-Cre mice predominantly developed clonally expanding and infiltrating CD4 þ and DP/SP CD4 þ T-cell lymphomas, leading to a premature death after 10-17 weeks; CD8-expressing malignant cells were never observed. 4 Pten flox/flox Â Mx-1-Cre mice died as soon as 4-6 weeks after Pten deletion, which was mostly due to development of infiltrating acute myeloid leukemias (AML), as Pten was deleted in all cells. 25 However, in this study, some mice were observed which developed malignant immature DP T-cell leukemias with the capacity to infiltrate the periphery, leading to a premature death with similar kinetics as AML-bearing Pten-deficient mice. In three murine Pten þ /À models, mice died between 16 and 56 weeks, 23, 24, 26 and polyclonal expansion and infiltration was shown to be limited to the SP CD4 þ compartment. 24 T-cellspecific CA-PI3K or myrAkt/PKB expression allowed clonal expansion of DP, SP CD4 þ or CD8 þ thymic populations, which sporadically infiltrated the periphery. 41, 46 The variability between different models may be dependent on a plethora of factors, including differences in deregulation of PI3K signaling, the number of mice analyzed and the use of models with different genetic backgrounds, as genetic background has been shown to influence the onset, the spectrum and the progression of tumorigenesis as a result of Pten loss. 47 In tumor-bearing T-cell-specific Pten-deficient mice, DN, DP and SP thymocytes and peripheral T cells expressed CD2, CD5 and CD44 at increased intensity at the cell surface, thought to be reflecting both increased expression and signaling capacity of the (pre-)TCR and elevated activation state of the cells. 15, 20, 21, 24 Simultaneously, the TCR complex subunits CD3e and TCRb were abundantly expressed at the cell surface of these populations, reflecting mature abTCR complex formation. ISP CD8 þ populations observed in the thymus and periphery of several tumor-bearing Pten flox/flox Â Lck-Cre mice did not upregulate TCR complex elements, but did upregulate CD2, CD5 and CD44. Whether this is reflective of increased pre-TCR signaling emanating from the low abundance of pre-TCR complexes at the cell surface to allow these cells to expand, or is a consequence of activation by other receptors, for example, cytokine receptors, remains to be determined. These observations indicated that in the majority of mice, transformation took place after b-selection, allowing the more mature thymocyte populations to give rise to all thymic and peripheral malignant DN, DP and SP populations. This is consistent with a recent report, which showed that CD3 þ cells isolated from T-cell lymphoma-bearing Ptendeficient mice were capable to induce T-cell lymphoma upon transplantation into irradiated wild-type mice. 25 However, in this study, T-cell lymphoma was also induced in recipients upon transfer of T-lineage blast precursors, indicating that precursor cells can give rise to and maintain T-cell lymphoma prior to TCRb chain rearrangements. Indeed, the observation that some of the T-cell lymphomas in Pten flox/flox Â Lck-Cre mice and Pten flox/flox Â CD4-Cre mice expanded polyclonally may reflect the presence of clonally expanding DN thymocyte precursors with TCRb genes in the germline configuration that are able to give rise to and maintain T-cell lymphomas that express a variety of rearranged TCRvb segments.
Although expanded thymocyte populations may contribute to premature death of T-cell-specific Pten-deficient mice due to increase in thymus size, acquirement of infiltrating capacities by Pten-deficient thymocytes was shown to be important for lethal T-cell lymphomagenesis; upon transplantation, only thymocytes that proved to possess the capability to infiltrate the periphery were able to establish lethal T-cell lymphoma in recipient mice, phenotypically similar to the peripheral T-cell populations observed in the donor mouse. Pten loss may therefore give rise to clonally expanding thymocyte populations that either remain in the thymus as hyperplastic cells, or acquire the capacity to infiltrate the periphery to be regarded as highly malignant cells. This is underlined by analyses of other tumor-bearing Pten flox/flox Â Lck-Cre mice and Pten flox/flox Â CD4-Cre mice that had expanded their thymic populations that did or did not give rise to peripheral malignant T-cell populations. The infiltrating capacity of malignant Pten-deficient thymocytes may be due to loss of Pten-mediated suppression of PI3K and Akt activity. 1 However, forced T-cellspecific myrAkt expression predominantly gave rise to exclusive thymic T-cell lymphomas that did not metastasize. 46 In addition, metastasis in a T-cell-specific CA-PI3K mouse model was specifically enhanced after deletion of p53, 41 a tumor suppressor protein whose loss has been indicated to induce Pten loss, 48 further underlining the importance of Pten loss in peripheral infiltration. As focal adhesion kinase (FAK) and Src homology 2 domain collagen-containing protein (Shc) are proteins that are directly negatively regulated by Pten, and have been indicated to be positively involved in cell motility and migration, 49 FAK and Shc may play an important role in metastasis of thymic T-cell lymphoma in a Pten-deficient background. T-cell-specific Pten-deficient mice TJ Hagenbeek and H Spits
Increased utilization of signals emanating from the (pre-)TCR by Pten flox/flox Â Lck-Cre and Pten flox/flox Â CD4-Cre thymocytes and peripheral cells in order to transform and expand was to be expected, as PI3K and Akt have been shown to be directly activated by the (pre-)TCR, 5, 19 activities no longer counteracted in the absence of Pten. However, other factors expressed by developing thymocytes that are involved in T-cell survival, proliferation and differentiation such as cKit, IL-7R, Notch receptors and CD28 are also known to utilize PI3K activity to positively transduce survival and proliferation signals. 2, 3, [11] [12] [13] [14] Pten deficiency may thus amplify PI3K-activating signals emanating from multiple activating factors, leading to thymic hyperplasia and subsequent T-cell lymphomagenesis. Independent studies confirmed the hyperreactive state of malignant thymocytes and peripheral T cells as a result of constitutive activation of the PI3K pathway. 4, 24, 41 Currently, we are analyzing the effects of deletions of (pre-)TCR components, the g common cytokine receptor component and the Notch1 receptor on T-cell lymphomagenesis induced by Pten deletion to understand the roles of these activation factors in this process.
The PI3K pathway is highly branched, and multiple downstream targets and regulators may play a role in T-cell lymphomagenesis in T-cell-specific Pten-deficient mice. Previously, we have shown that Akt/PKB is constitutively phosphorylated in tumor-bearing mice as a result of Pten deletion. 28 Downstream targets of Akt/PKB that have been indicated to be important modulators of thymocyte development and lymphomagenesis are GSK3b and its downstream target b-catenin, 9,46 TSC2 and its downstream target mTOR, 8, 25, 50 several members of forkhead family of transcription factors, 9 nuclear factor-kB, 10,51,52 Bcl-2 9 and p27 kip1 . 9 The importance of these downstream targets in T-cell lymphomagenesis in Pten flox/flox Â Lck-Cre mice and Pten flox/flox Â CD4-Cre mice is currently under investigation. Most human childhood and adult T-cell acute lymphoblastic leukemias (T-ALL) are characterized by deletion of Pten expression, constitutively activation of Akt/PKB, clonal expansion and infiltration of T cells displaying immature thymic phenotypes and sensitivity to chemical compounds that specifically inhibit PI3K-mediated signal transduction pathways. 27, 50 To study the characteristics and biology of human T-ALL in more detail, and to develop more effective treatment for human T-ALL using agents that specifically target components of PI3K-dependent signal transduction pathways, Pten flox/flox Â Lck-Cre mice and Pten flox/flox Â CD4-Cre mice may prove to be efficient models.
